VIDEO : The company behind GR-1 plans to release 100 units by the end of 2023 mainly targeting robotic R&D labs. GR-1 will be able to carry patients from the bed to wheelchairs and help pick up objects.
Research led by Sichuan University and Huazhong University of Science and Technology, China, has revealed genetic mechanisms that could prolong healthy aging. In the paper, titled “Partial inhibition of class III PI3K VPS-34 ameliorates motor aging and prolongs health span,” published in PLOS Biology, the team details the methods they used to narrow down the potential genomic pathways to a single gene that could be critical to extending healthy human longevity.
With a combination of genetic manipulation, behavioral assays, microscopy techniques, and electrophysiology, the researchers investigated the role of VPS-34 in motor aging. These methods allowed the researchers to gain insights into the molecular mechanisms underlying motor aging and the effects of VPS-34 inhibition on motor function, synaptic transmission, and muscle integrity.
According to the authors, increased life expectancy in recent decades has not been accompanied by a corresponding increase in health span. Aging is characterized by the decline of multiple organs and tissues and motor aging, in particular, leads to frailty, loss of motor independence, and other age-related issues. Identifying mechanisms for therapeutics to delay motor aging is crucial for promoting healthy aging.
Consider it a technological solution to the problem of death.
Over the last couple years, I’ve been writing about creating ghosts — perhaps an inevitability in the midst of a pandemic.
Artur Sychov, founder and CEO of metaverse company Somnium Space, has joined the quest against loss. Using motion capture and voice data, he wants to create duplicate avatars that can move as you moved and speak as you spoke, using your voice.
For decades, people have arranged to freeze their bodies after death, dreaming of resurrection by advanced future medicine.
Bryan Johnson’s anti-aging routine costs him $2 million a year, and he’s constantly monitored. Yet, the tech CEO says he’s never been happier.
Starting at 12:40 Liz asks what would your perfect virtual world be like. Not sure what my home world would be like, a Maldives island, an orbital ring colony perhaps. I think my main form of entertainment would be to adventure in the worlds people will create, and perhaps help build them. Someone will detail the 30 million worlds of A Galaxy Far Far Away and go play in it, someone will create a Star Trek Galaxy, D&D, Niven’s Known Space, Potter-verse, LOTR, and so on.
Only a handful of people in the entire world are aware of the work that is going on to increase the lifespan of #humans. Not just in terms of numbers, but also in terms of the quality of life. Most people today are unable to imagine living beyond 80–90, and they absolutely cannot imagine living an active life at 80–90 or beyond, to say nothing of living forever, and leading an active life forever.
Continue reading “Ep#09 Liz & Sar: Did you know you can live forever?” »
In a groundbreaking study, researchers have unlocked a new frontier in the fight against aging and age-related diseases. The study, conducted by a team of scientists at Harvard Medical School, has published the first chemical approach to reprogram cells to a younger state. Previously, this was only achievable using a powerful gene therapy.
On July 12, 2023, researchers from Harvard Medical School, University of Maine and Massachusetts Institute of Technology (MIT) published a new research paper in Aging, titled, “Chemically induced reprogramming to reverse cellular aging.”
The team’s findings build upon the discovery that the expression of specific genes, called Yamanaka factors, could convert adult cells into induced pluripotent stem cells (iPSCs). This Nobel Prize-winning discovery raised the question of whether it might be possible to reverse cellular aging without causing cells to become too young and turn cancerous.
In a groundbreaking study, researchers have unlocked a new frontier in the fight against aging and age-related diseases. The study, conducted by a team of scientists at Harvard Medical School, has published the first chemical approach to reprogram cells to a younger state. Previously, this was only achievable using a powerful gene therapy.
Researchers from Harvard Medical School, University of Maine and Massachusetts Institute of Technology (MIT) published a new research paper in Aging, titled, “Chemically induced reprogramming to reverse cellular aging.”
For cellular agriculture—a technique that grows meat in bioreactors—to successfully feed millions, numerous technological hurdles must be conquered. The production of muscle cells from sources such as chicken, fish, cows, and more will need to increase to the point where millions of metric tons are yielded annually.
Researchers at the Tufts University Center for Cellular Agriculture (TUCCA) have made strides toward this objective by developing immortalized bovine muscle stem cells (iBSCs). These cells possess a rapid growth rate and the ability to divide hundreds of times, potentially even indefinitely, furthering the potential for large-scale meat production.
This advance, described in the journal ACS Synthetic Biology, means that researchers and companies around the globe can have access to and develop new products without having to source cells repeatedly from farm animal biopsies.
A new study conducted by researchers at Washington University School of Medicine in St Louis has explored the composition of gut bacteria in individuals in the earliest stage of Alzheimer’s disease. The research, which is published in Science Translational Medicine, not only identifies potential indicators of heightened dementia risk, but also offers prospects for developing microbiome-altering preventive treatments to combat cognitive decline.
Longevity. Technology: Previously, science has noted differences in the gut microbiomes of individuals with symptomatic Alzheimer’s compared with their healthy counterparts. However, the current study delves deeper, focusing on the gut microbiomes of individuals in the crucial pre-symptomatic phase. During this phase, individuals accumulate amyloid beta and tau proteins in their brains without exhibiting neurodegeneration or cognitive decline, which can persist for over two decades. Earlier diagnosis would enable people to access support and resources, plan for the future and well as onboarding treatments that could slow the progression of the disease. An idea of future numbers of patients would also allow health care infrastructure to be better prepared.
The researchers evaluated participants who volunteered at the Charles F and Joanne Knight Alzheimer Disease Research Center at Washington University, specifically selecting cognitively normal individuals. These participants provided samples of stool, blood, and cerebrospinal fluid, recorded their dietary habits, and underwent PET and MRI brain scans.
